The same brain cells linked to disorientation in Alzheimer's disease have been preserved—and even slightly increased—across ...

An announcement from Pharmaust Limited ( ($AU:NUZ) ) is now available. Neurizon Therapeutics Limited announced the results of its Annual General ...

The U.S. Food and Drug Administration has approved Novartis' gene therapy for patients with a rare muscle disorder, the drugmaker said on Monday.

The FDA approved the intrathecal gene therapy onasemnogene abeparvovec (Itvisma) to treat spinal muscular atrophy (SMA) in ...

One of the sons of the late Doddie Weir has said he feels it is time to “step up” as he was announced as captain of the Scotland team in a fundraising challenge raising money for research into motor ...

Control Bionics Ltd. ( ($AU:CBL) ) has shared an update. Control Bionics Limited announced the resignation of its chairman, Dr. Samuel Straface, ...

A preclinical study of M102 showed it slowed the progression of MND and preserved muscle function in mice. Scientists have discovered a new medicine that protects nerve cells damaged by motor neurone ...

Alzheimer's is a devastating disease that results in memory loss and cognitive decline. It's caused by brain cells dying and the brain itself shrinking from a buildup of proteins. Millions of seniors ...

A newly identified disorder, MINA syndrome, results from a mutation in the NAMPT protein that deprives motor neurons of energy, leading to severe movement problems. The discovery not only deepens ...